4.7 Article

Electrochemical aptasensor for NS1 detection: Towards a fast dengue biosensor

Journal

TALANTA
Volume 233, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.talanta.2021.122527

Keywords

Aptamer; Dengue; NS1; Biosensor; Impedimetric

Funding

  1. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]
  2. FAPESP [2013/26133-7, 2017/24201-6]
  3. CNPq [308713/2018-4]

Ask authors/readers for more resources

An electrochemical biosensor for NS1 detection was developed in this study by optimizing the molar ratio between aptamers and MCH, achieving high sensitivity and low detection limits for NS1 detection in the early stages of disease. By adding bovine serum albumin to stabilize NS1, the sensor accurately detected NS1 from different Dengue serotypes.
Dengue is one of the most commonly neglected tropical diseases transmitted by Aedes aegypti infected with Dengue virus. This virus belongs to the gender Flavivirus and produces a non-structural protein 1 (NS1), which is an important biomarker found at high levels in blood in early disease stage. Therefore, this study focused on the development of an electrochemical biosensor for NS1 detection using DNA aptamers. Gold electrodes were co-immobilized with specific aptamers and 6-mercapto-1-hexanol (MCH) to obtain a self-assembled monolayer. The molar ratio between aptamers and MCH was optimized and the platform characterized by electrochemical impedance spectroscopy and atomic force microscopy. Bovine serum albumin was added in NS1 solution to stabilize it and block the surface to avoid non-specific interactions. The biosensor performance was tested with NS1 protein serotype 4 (in phosphate saline buffer and human serum) and with a solution of serotype 1 in human serum. The results showed a sensitivity of 2.9%, 2.7% and 1.7% per decade, respectively, and low limit of detection (0.05, 0.022 and 0.025 ng/mL). The platform was also tested with Envelope protein as negative control. Furthermore, the aptamer sensor was able to detect NS1 in clinical range and it is a promising candidate for a new class for miniaturized point-of-care device for different Dengue serotypes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available